CarlsMed is a small, risky 3D-printed spinal implant company; its founder's expertise and mission make it promising, it belongs in a diversified portfolio, and the investment could double over the next five years.

Carls Mead is a unique company; it is not a $20 billion or $400 billion company. This is a company whose subsequent sales amount to approximately $50 million .

This is a kind of creative project for someone who has a lot of experience in medical devices and products. His father had to undergo spinal surgery, so he asked his son: "Can you, with your experience, customize the surgery that I will undergo in any way?"

That was the impetus for the creation of CarlsMed, a company that 3D-prints spinal implants.

So, when you go for spine surgery today, you generally get general implants, and in many cases you will have to go back and have corrective surgery later. This company is trying to reduce the number of revision surgeries after spinal surgery by printing implants that match the patient's anatomy using 3D technology .

He did this for his father. It is a small company in the public markets. Therefore, it is a much riskier investment . It belongs to a diversified investment portfolio. You've heard me say this many times before, but I love these passion projects where someone has real expertise in the field and is on a mission to create something of importance, and it ends up becoming a successful and thriving business.

And I think we're going to see some great things from Carls Mead, whose trading symbol is c a r l in the public markets. I believe we can double our investment in this company over the next five years.